thioflavin t has been researched along with Acute Myelogenous Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Accordi, B; Aveic, S; Basso, G; Locatelli, F; Masetti, R; Micalizzi, C; Pigazzi, M; Santoro, N; Viola, G | 1 |
1 other study(ies) available for thioflavin t and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Targeting BAG-1: a novel strategy to increase drug efficacy in acute myeloid leukemia.
Topics: Antineoplastic Agents; Benzothiazoles; Child; Child, Preschool; DNA-Binding Proteins; Drug Delivery Systems; Drug Therapy, Combination; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Infant; Leukemia, Myeloid, Acute; Thiazoles; Transcription Factors | 2015 |